Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
TrivarX Limited (MDBIF)
OTHER OTC:MDBIF
Holding MDBIF?
Track your performance easily
MDBIF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.05
Previous Close$0.03
Volume875.00
Average Volume (3M)N/A
Market Cap
$4.65M
Enterprise Value$4.04M
Total Cash (Recent Filing)AU$1.03M
Total Debt (Recent Filing)AU$66.42K
Price to Earnings (P/E)―
Beta2.65
Next Earnings
Feb 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding207,529,690
10 Day Avg. Volume88
30 Day Avg. VolumeN/A
Standard Deviation0.55
R-Squared0.00035
Alpha0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)86.75
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
TrivarX Limited News
PremiumCompany Announcements
TrivarX Director’s Share Acquisition Boosts Stake
PremiumCompany Announcements
TrivarX Limited: Director’s Significant Share AcquisitionPremiumCompany Announcements
TrivarX Limited Updates Director’s Securities HoldingsPremiumCompany Announcements
TrivarX Limited Secures Shareholder Support for Key ResolutionsPremiumCompany Announcements
TrivarX Advances Mental Health Screening InnovationsPremiumCompany Announcements
TrivarX Unveils Innovative Depression Screening ToolPremiumCompany Announcements
TrivarX Limited’s AI Algorithm Shows Promise in Depression ScreeningPremiumCompany Announcements
TrivarX Limited Plans New Securities IssueOptions Prices
Currently, No data available
---
Ownership Overview
MDBIF FAQ
What was TrivarX Limited’s price range in the past 12 months?
TrivarX Limited lowest stock price was <$0.01 and its highest was $0.05 in the past 12 months.
What is TrivarX Limited’s market cap?
Currently, no data Available
When is TrivarX Limited’s upcoming earnings report date?
TrivarX Limited’s upcoming earnings report date is Feb 28, 2025 which is in 67 days.
How were TrivarX Limited’s earnings last quarter?
TrivarX Limited released its earnings results on Aug 28, 2024. The company reported >-$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-$0.001.
Is TrivarX Limited overvalued?
According to Wall Street analysts TrivarX Limited’s price is currently Overvalued.
Does TrivarX Limited pay dividends?
TrivarX Limited does not currently pay dividends.
What is TrivarX Limited’s EPS estimate?
TrivarX Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TrivarX Limited have?
TrivarX Limited has 464,870,450 shares outstanding.
What happened to TrivarX Limited’s price movement after its last earnings report?
TrivarX Limited reported an EPS of >-$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of TrivarX Limited?
Currently, no hedge funds are holding shares in MDBIF
---
TrivarX Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
―
20 days / 200 days
Momentum
25.00%
12-Months-Change
Fundamentals
Return on Equity
-17.32%
Trailing 12-Months
Asset Growth
38.23%
Trailing 12-Months
Company Description
TrivarX Limited
Medibio Ltd is a medical technology company. The principal activity of the company is conducting clinical research, product development and early stage commercialisation of mental health technology using objective biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions. It primarily serves both consumer and healthcare provider markets. In addition, the company offers various psychological services to customers in Australia. The company operates in two geographical markets, being Australia and the United States.
---
Technical Analysis
---